admin

Whether we’re struggling with FOMO, or constantly falling into comparison traps, comparing ourselves to others is making us miserable. But it doesn’t have to be this way When was the last time you felt the prickly sting of comparison? You know the feeling: the hot frustration that starts in your belly, and rises to your
0 Comments
Quarantining at home for the past few months considerably reduced professional and socializing activities. Added to the sense of isolation from stay-at-home orders, other factors including unemployment, financial troubles, and the threat of COVID-19 infection and death has significantly increased stress levels for many people. One researcher from the United States recently published a piece suggesting that psychosocial
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Here are the coronavirus stories Medscape’s editors around the globe think you need to know about today: Blood Test Signals Risk? A low lymphocyte count in people presenting to the hospital with COVID-19 could help physicians identify those at higher risk
0 Comments
Two experts in geriatric diabetes are offering some contemporary practical recommendations for diabetes management in older adults during the COVID-19 pandemic.   The viewpoint, entitled, ”Caring for Older Adults With Diabetes During the COVID-19 Pandemic,” was published online in JAMA Internal Medicine by Medha N. Munshi, MD, director of the geriatrics program at the Joslin Diabetes Center,
0 Comments
avacopan Treatment for ANCA-Associated Vasculitis ChemoCentryx Submits New Drug Application to the U.S. FDA for Avacopan in ANCA-Associated Vasculitis Print this page MOUNTAIN VIEW, Calif., July 09, 2020 (GLOBE NEWSWIRE) – ChemoCentryx, Inc., (NASDAQ: CCXI) today confirmed that the Company has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for avacopan for the treatment
0 Comments
Print this page CAMBRIDGE, Mass.–(BUSINESS WIRE) July 09, 2020 –Ipsen Biopharmaceuticals, an affiliate of Ipsen (Euronext: IPN; ADR: IPSEY), announced today that the United States Food and Drug Administration (FDA) has approved the expanded use of Dysport (abobotulinumtoxinA) in pediatric patients. When Dysport was first FDA-approved in 2016 for pediatric lower limb spasticity, Ipsen was
0 Comments
Beads hang from tree limbs on the campus of Tulane University, New Orleans, Louisiana. Education Images | Getty Images Tulane University, which has long been ranked as one of the best party schools in the nation, is threatening expulsion for students attending big bashes after “truly shameful” partying drew negative attention to the New Orleans
0 Comments
Extremely preterm children have very low birth weights, underdeveloped organs, and risks of long-term problems or disabilities. Antenatal treatment — therapy given before birth — can improve outcomes in preterm children. Statistical analysis of medical records can tell clinicians which antenatal treatments can best protect against severe neurodevelopmental impairment or death. The UAB News Studio
0 Comments
Hydroxychloroquine (HCQ) helped reduce recurrent maternal autoantibody-mediated congenital heart block (CHB) in fetuses, an open-label study suggested. Anti-SSA/Ro-positive mothers who had had a previous pregnancy complicated by CHB who took HCQ 400 mg daily, starting before completion of gestational week 10, had a 7.4% rate of clinically-relevant fetal CHB (second- or third-degree) at any time
0 Comments
Use your voice to make a difference. If you’re passionate about being a better ally, please continue to do your research, educate yourself, and speak up against injustice 1. Page-turners Me and White Supremacy: How to Recognise Your Privilege, Combat Racism and Change the World Many of us are unaware of just how much white
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Here are the coronavirus stories Medscape’s editors around the globe think you need to know about today. Shelter-in-Place Orders Shelter-in-place orders (SIPOs), also known as stay-at-home orders, were associated with reduced growth rates for COVID-19–related hospitalizations and deaths during the pandemic’s
0 Comments
Print this page FOSTER CITY, Calif.–(BUSINESS WIRE)–Jul. 10, 2020– Gilead Sciences, Inc. (Nasdaq: GILD) today announced additional data on remdesivir, an investigational antiviral for the treatment of COVID-19, adding to the available body of knowledge on treatment outcomes with remdesivir. The data are being presented at the Virtual COVID-19 Conference as part of the 23rd International AIDS Conference (AIDS 2020: Virtual)
0 Comments
Print this page NORTH CHICAGO, Ill., July 9, 2020 /PRNewswire/ — Allergan, an AbbVie (NYSE: ABBV) company, today announced that the U.S. Food and Drug Administration (FDA) approved a supplemental Biologics License Application (sBLA) that supports expanded use of Botox® for the treatment of spasticity in pediatric patients 2 years of age and older, including
0 Comments